Pascal Colosetti
  • E-mail :[email]
  • Phone : +33 4 26 23 59 22
  • Location : Lyon, France
Last update 2016-11-25 09:53:55.072

Pascal Colosetti Inserm Research Engineer

Course and current status

Professional experience

2016-Today   Research Engineer within Inserm U1060-CarMeN Team 2 (S. Rome's Group, Lyon, France): Extracellular vesicles in muscle and metabolic disorders

Member of the Inserm Scientific Council (2012-2017)


 2001-2016   Research Engineer within Inserm U1065-C3M Team 2 (P. Auberger, Nice, France): Extracellular vesicles (microvesicles and exosomes) in cancer, chemoresistance and inflammation


1997-2001   Research Engineer within Inserm U442 (Orsay, France): InsP3R expression and regulation during cell polarization (J.-P. Mauger)

 

Diplomas and qualifications

2011   International Cancer Technology Transfer fellow at the Krefting Research Centre-Göteborg University, (Prof. J. Lötvall, Sweden) (UICC-ICRETT grant)

2008   Inter-university diploma on acquired chromosomal pathologies (Bordeaux, Grenoble, Lille, Lyon, Marseille, Nice and Paris-Sud Universities)

2000   Transgenesis and homologous recombination diploma (Paris 6 University)

1994-1997   Postdoctoral fellow at the Laboratoire de Recherche en Oncologie of the Centre Alexis Vautrin (Nancy, France): Anticancer treatment resistance (Prof. J.-L. Merlin)

1991-1994   Postdoctoral fellow at the Ludwig Institute for Cancer Research (Uppsala, Sweden):  TGF-beta  activation and LTBP expression (Prof. C.-H. Heldin and Prof. K. Miyazono)

1991-1987   PhD in Biomedical Engineering at the Inserm U284 (Nancy University, France): TGF-beta 1 purification, a human platelet derived growth factor (C. Rivat)


Scientific summary

After completing my PhD on the TGF-beta 1 purification, a human platelet derived growth factor, at the Inserm U284 in Nancy, I’ve done a postdoctoral fellow at the Ludwig Institute for Cancer Research in Uppsala on TGF-beta activation and LTBP expression; followed by an other fellow at the Laboratoire de Recherche en Oncologie (Centre Alexis Vautrin in Nancy) coordinating a cancer treatment resistance project.

I then joined as Research Engineer the Inserm U442 in Orsay to study the InsP3R expression during cell polarization.

I next joined the Team 2 of the Inserm U1065-C3M held by Patrick Auberger and involved in cell death, differentiation, inflammation and cancer; last years, I developed skills in the characterization of extracellular vesicles (microvesicles and exosomes) in cancer, chemoresistance and inflammation.

I'm now part of the Sophie Rome's group within team 2 of Inserm U1060-CarMeN in Lyon to study extracellular vesicles in muscle and metabolic disorders.

I'm also involved in the Inserm Scientific Council (2012-2017).

Image d’exemple